Chapter 12 : Moral

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Moral, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818029/9781555812225_Chap12-1.gif /docserver/preview/fulltext/10.1128/9781555818029/9781555812225_Chap12-2.gif


The use of recombinant DNA research technology in the ensuing decade has resulted in extraordinary scientific progress and significant practical benefits. Since the initial first years of controversy over new technology for molecular genetics, our successors have been faced with the realization that Asilomar was only the first act. In the last decades leading to the millennium, new controversies over molecular genetics have appeared, including, most prominently, the attempts to supply substitute genes for humans having serious illnesses. The early proposals in legislation to provide ‘‘commissions,’’ using a minority of scientists to create the matrix while setting the majority of members off on a hunt for social and ethical issues of recombinant DNA research, were patently premature. Enormous power has been inherited by humankind in this new biology. The resulting entrepreneurial forces represent the only way in which new discoveries will be rapidly converted to inventions, enriching the economy and offering myriad possibilities for improved health practices in the future.

Citation: Fredrickson D. 2001. Moral, p 278-280. In The Recombinant DNA Controversy. ASM Press, Washington, DC. doi: 10.1128/9781555818029.ch12
Highlighted Text: Show | Hide
Loading full text...

Full text loading...



This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error